Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDMD Baird Medical Investment	$2.00 -2.4%	$3.41	$1.05 ▼ $12.50	$73.24M	-1	277,658 shs	301,906 shs
DRIO DarioHealth	$0.55 +27.2%	$0.63	$0.38 ▼ $1.55	$19.67M	1.24	203,837 shs	662,625 shs
NTRB Nutriband	$6.31 +1.4%	$7.72	$3.72 ▼ $11.78	$69.38M	1.13	195,362 shs	14,398 shs
VANI Vivani Medical	$1.21 -0.8%	$1.35	$0.91 ▼ $1.80	$72.28M	2.99	150,939 shs	54,953 shs

10 Best Stocks to Own: Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDMD Baird Medical Investment	-2.44%	-22.48%	-7.83%	-59.18%	+199,999,900.00%
DRIO DarioHealth	+27.20%	+26.20%	-21.46%	-23.61%	-40.80%
NTRB Nutriband	+1.45%	+0.16%	-27.22%	+15.15%	+9.59%
VANI Vivani Medical	-0.82%	-4.72%	-22.44%	+7.08%	-12.95%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DRIO DarioHealth	1.5213 of 5 stars	3.3	0.0	0.0	0.0	1.0	0.8	1.3
NTRB Nutriband	3.3326 of 5 stars	3.5	5.0	0.0	0.0	2.6	1.7	0.6
VANI Vivani Medical	2.1972 of 5 stars	3.5	3.0	0.0	0.0	1.7	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BDMD Baird Medical Investment	0.00	N/A	N/A	N/A
DRIO DarioHealth	2.67	Moderate Buy	$2.00	263.64% Upside
NTRB Nutriband	3.00	Buy	$13.00	106.02% Upside
VANI Vivani Medical	3.00	Buy	$4.00	230.58% Upside

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A	N/A
DRIO DarioHealth	$27.04M	0.93	N/A	N/A	$1.41 per share	0.39
NTRB Nutriband	$2.14M	32.88	N/A	N/A	$0.58 per share	10.88
VANI Vivani Medical	N/A	N/A	N/A	N/A	$0.08 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BDMD Baird Medical Investment	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
DRIO DarioHealth	-$42.75M	-$0.66	N/A	N/A	N/A	-162.73%	-65.89%	-39.03%	11/6/2025 (Estimated)
NTRB Nutriband	-$10.48M	-$0.90	N/A	N/A	N/A	-415.93%	-68.25%	-60.40%	9/2/2025 (Estimated)
VANI Vivani Medical	-$23.49M	-$0.45	N/A	N/A	N/A	N/A	-194.66%	-68.64%	N/A

Latest DRIO, BDMD, VANI, and NTRB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/2/2025	N/A	NTRB Nutriband	-$0.17	N/A	N/A	N/A	$0.71 million	N/A
8/13/2025	Q2 2025	VANI Vivani Medical	-$0.10	-$0.12	-$0.02	-$0.12	N/A	N/A
5/30/2025	Q1 2026	NTRB Nutriband	-$0.13	-$0.12	+$0.01	-$0.12	$0.71 million	$0.67 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A
DRIO DarioHealth	N/A	N/A	N/A	N/A	N/A
NTRB Nutriband	N/A	N/A	N/A	N/A	N/A
VANI Vivani Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BDMD Baird Medical Investment	N/A	N/A	N/A
DRIO DarioHealth	0.48	3.30	2.83
NTRB Nutriband	0.01	3.71	3.48
VANI Vivani Medical	N/A	1.30	1.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BDMD Baird Medical Investment	19.78%
DRIO DarioHealth	33.39%
NTRB Nutriband	19.70%
VANI Vivani Medical	6.78%

Insider Ownership

Company	Insider Ownership
BDMD Baird Medical Investment	78.90%
DRIO DarioHealth	11.20%
NTRB Nutriband	54.09%
VANI Vivani Medical	46.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BDMD Baird Medical Investment	N/A	35.73 million	7.54 million	N/A
DRIO DarioHealth	200	45.50 million	40.40 million	Optionable
NTRB Nutriband	10	11.15 million	5.12 million	Not Optionable
VANI Vivani Medical	20	59.24 million	31.76 million	Optionable

DRIO, BDMD, VANI, and NTRB Headlines

Recent News About These Companies

Could Dogs Get Their Version Of Ozempic? Scientists Test "Ozempup" For Pet Obesity

August 21 at 11:28 AM | ndtv.comN

After Ozempic, is “Ozempup” on the way? Scientists explore weight-loss jabs for obese pet dogs-- All details here

August 21 at 3:54 AM | msn.com

Vivani Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference on Innovative Drug Implant Technology

August 20 at 8:51 AM | quiverquant.comQ

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

August 20 at 8:30 AM | globenewswire.com

Fido get fat? Ozempic for dogs could hit the market in three years

August 19 at 7:29 PM | msn.com

Vivani Medical (NASDAQ:VANI) Stock Price Down 0.8% After Earnings Miss

August 15, 2025 | marketbeat.com

Vivani Medical (NASDAQ:VANI) Announces Quarterly Earnings Results

August 15, 2025 | marketbeat.com

Vivani closes $10M financing, advances GLP-1 implant

August 14, 2025 | drugdeliverybusiness.comD

Vivani Medical, Inc.: Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

August 14, 2025 | finanznachrichten.de

Vivani Medical (NASDAQ:VANI) Stock Price Down 0.8% Following Weak Earnings

August 14, 2025 | americanbankingnews.com

Vivani Medical Reports Q2 2025 Results and $10M Financing

August 13, 2025 | tipranks.com

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second ...

August 13, 2025 | bakersfield.comB

Vivani Medical Secures $10M Through Share Purchase Agreement

August 13, 2025 | msn.com

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

August 13, 2025 | globenewswire.com

Vivani Medical (VANI) to Release Quarterly Earnings on Tuesday

August 6, 2025 | marketbeat.com

Vivani Medical, Inc. (NASDAQ:VANI) Sees Large Growth in Short Interest

August 2, 2025 | marketbeat.com

Vivani Medical (NASDAQ:VANI) Shares Up 0.6% - Here's What Happened

July 23, 2025 | marketbeat.com

3 Penny Stocks With Market Caps Over $30M To Consider

July 16, 2025 | finance.yahoo.com

Vivani Medical Insiders Added US$5.29m Of Stock To Their Holdings

June 30, 2025 | uk.finance.yahoo.com

Vivani Medical shareholders elect board and approve key proposals at annual meeting - Investing.com

June 27, 2025 | investing.com

Vivani Medical Appoints Anthony Baldor as Chief Financial Officer

June 11, 2025 | manilatimes.netM

New MarketBeat Followers Over Time

Media Sentiment Over Time

DRIO, BDMD, VANI, and NTRB Company Descriptions

Baird Medical Investment NASDAQ:BDMD

$2.00 -0.05 (-2.44%)

As of 08/21/2025 04:00 PM Eastern

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

DarioHealth NASDAQ:DRIO

$0.55 +0.12 (+27.20%)

Closing price 08/21/2025 03:59 PM Eastern

Extended Trading

$0.55 -0.01 (-0.91%)

As of 08/21/2025 07:59 PM Eastern

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Nutriband NASDAQ:NTRB

$6.31 +0.09 (+1.45%)

Closing price 08/21/2025 04:00 PM Eastern

Extended Trading

$6.38 +0.07 (+1.03%)

As of 08/21/2025 05:13 PM Eastern

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Vivani Medical NASDAQ:VANI

$1.21 -0.01 (-0.82%)

Closing price 08/21/2025 04:00 PM Eastern

Extended Trading

$1.23 +0.02 (+1.24%)

As of 08/21/2025 04:10 PM Eastern

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time